PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
4 hedge funds and large institutions have $9.78M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
55% more capital invested
Capital invested by funds: $6.3M → $9.78M (+$3.48M)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$523K |
| 2 |
Millennium Management
New York
|
-$10.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $4.61M | – | – | – |
|
|
BI
2
BVF Inc
San Francisco,
California
| $4.55M | – | – | – |
|
|
PF
3
Phoenix Financial
Givatayim,
Israel
| $513K | – | – | – |
|
|
4
Millennium Management
New York
| $112K | -$10.8K | -224 | -13% |
|
|
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
| – | -$523K | -11,784 | Closed |
|
PHXM Hedge Fund Activity: Q4 2019 in Review
4 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q4 2019, worth a combined $9.78M — up 55% from $6.3M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PHXM and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Sphera Funds Management, exiting entirely with an estimated $523K sold.
- 4 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q4 2019, down from 5 in Q3 2019.
- Funds reported $9.78M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q4 2019, up 55% quarter-over-quarter.
- 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q4 2019 and 1 closed out, a net change of -1 holder.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q4 2019 was Sphera Funds Management, an estimated $523K sold.
Based on aggregated 13F filings for Q4 2019.